Teva forecasts it will be a “significant period of time” before both criminal and civil proceedings over alleged generic drug price fixing in the US move to trial, in the latest update involving the long-running saga that continues to cast a shadow over the Israeli giant.
“I think it's fair to say that the COVID-19 pandemic in the US has slowed down proceedings in the legal...